Rationale: Whether patients with coronavirus disease (COVID-19) may benefit from
extracorporeal membrane oxygenation (ECMO) compared with conventional invasive …

Background Patients with COVID-19 who develop severe acute respiratory distress
syndrome (ARDS) can have symptoms that rapidly evolve to profound hypoxaemia and …

Rationale: The role of and needs for extracorporeal membrane oxygenation (ECMO) at a
population level during the coronavirus disease (COVID-19) pandemic have not been …

ECMO has an established role in the treatment of severe forms of ARDS. Current data
suggest adherence to the currently accepted algorithm for management of ARDS, including …

Purpose Limited data are available on venovenous extracorporeal membrane oxygenation
(ECMO) in patients with severe hypoxemic respiratory failure from coronavirus disease 2019 …

OBJECTIVES: To compare complications and mortality between patients that required
extracorporeal membrane oxygenation (ECMO) support for acute respiratory distress …

It remains unclear to what extent the outcomes and complications of extracorporeal
membrane oxygenation (ECMO) therapy in COVID-19 patients with acute respiratory …

Background To inform future research and practice, we aimed to investigate the outcomes of
patients who received extracorporeal membrane oxygenation (ECMO) for acute respiratory …

Extracorporeal membrane oxygenation (ECMO) is increasingly being used for patients with
severe respiratory failure and has received particular attention during the coronavirus …

Background There are several reports of extracorporeal membrane oxygenation (ECMO)
use in patients with coronavirus disease 2019 (COVID-19) who develop severe acute …